[ TABLE OF CONTENT ]

1 INTRODUCTION OF GLOBAL MEDICAL SIMULATION MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY: MEDICAL SIMULATION MARKET

3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS

4 GLOBAL MEDICAL SIMULATION MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE

5 GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICES
5.1 OVERVIEW
5.2 MODEL-BASED SIMULATION
5.2.1 PATIENT SIMULATION
5.2.1.1 TASK TRAINER SIMULATION
5.2.1.2 MANIKIN-BASED SIMULATION
5.2.1.2.1 ADULT
5.2.1.2.2 PEDIATRIC
5.2.1.2.3 NEONATAL
5.2.1.3 HYBRID MANIKIN-BASED BASED SIMULATION (WITH AR)
5.2.1.4 STANDARDIZED PATIENT SIMULATION
5.2.2 SURGICAL SIMULATION
5.2.2.1 LAPAROSCOPIC SURGICAL SIMULATORS
5.2.2.2 ARTHROSCOPIC SURGICAL SIMULATORS
5.2.2.3 CARDIOVASCULAR SIMULATORS
5.2.2.4 GYNECOLOGY SIMULATORS
5.2.2.5 ORTHOPEDIC SIMULATORS
5.2.2.6 SPINE SIMULATORS
5.2.2.7 ENDOVASCULAR SIMULATORS
5.2.2.8 OTHERS
5.2.3 ULTRASOUND SIMULATION
5.2.3.1 ANESTHESIA
5.2.3.2 CARDIOLOGY
5.2.3.3 EMERGENCY MEDICINE
5.2.3.4 INTENSIVE CARE UNIT
5.2.3.5 OB/GYN
5.2.3.6 RADIOLOGY
5.2.3.7 OTHERS (UROLOGY, GENERAL NURSING, PEDIATRICS)
5.2.4 WEB-BASED SIMULATION
5.2.4.1 SIMULATION SOFTWARE
5.2.4.2 PERFORMANCE RECORDING SOFTWARE
5.2.4.3 VIRTUAL TUTORS
5.2.4.4 LEARNING MANAGEMENT SOFTWARE
5.3 SIMULATION TRAINING SERVICES
5.4 VENDOR-BASED TRAINING
5.5 CUSTOM CONSULTING SERVICES
5.6 EDUCATIONAL SOCIETIES

6 GLOBAL MEDICAL SIMULATION MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 3D PRINTING
6.3 PROCEDURAL REHEARSAL TECHNOLOGY
6.4 VIRTUAL PATIENT SIMULATION

7 GLOBAL MEDICAL SIMULATION MARKET, BY END-USER
7.1 OVERVIEW
7.2 MILITARY ORGANIZATIONS
7.3 ACADEMIC INSTITUTES
7.4 HOSPITALS
7.5 RESEARCH
7.6 OTHERS

8 GLOBAL MEDICAL SIMULATION MARKET, BY GEOGRAPHY
8.1 OVERVIEW

8.2 NORTH AMERICA

8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO

8.3 EUROPE

8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE

8.4 ASIA PACIFIC

8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC

8.5 MIDDLE EAST & AFRICA

8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA

8.6 SOUTH AMERICA

8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA

9 GLOBAL MEDICAL SIMULATION MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES

10 COMPANY PROFILES

10.1 CAE, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.2 GAUMARD SCIENTIFIC COMPANY, INC.
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.3 INTELLIGENT ULTRASOUND GROUP PLC.
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.4 KYOTO KAGAKU CO. LTD.
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.5 LAERDAL MEDICAL AS
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.6 LIMBS AND THINGS, LTD.
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.7 MENTICE AB
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.8 OPERATIVE EXPERIENCE, INC.
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.9 SIMULAB CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS

10.10 VIRTAMED AG
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS